Articles From: CombiMatrix's SNP-Based Miscarriage Analysis Test Granted Conditional Approval From New York State Department of Health to Apache reports 18 percent year-over-year pro forma North American onshore liquids growth for second-quarter 2014


IRVINE, Calif., July 31, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) , a molecular diagnostics company performing DNA-based testing services for developmental disorders and cancer diagnostics, today announced that its SNP-based chromosomal microarray analysis (CMA) test for miscarriage analysis, the CombiSNP™ Array for Pregnancy Loss , or products of conception, has received conditional approval from the New York Department of Health (NYDOH). This approval is for testing on fresh and formalin fixed paraffin embedded (FFPE) patient samples.
Sign-up for CombiMatrix's SNP-Based Miscarriage Analysis Test Granted Conditional Approval From New York State Department of Health investment picks
2014/7/31
Strategic Initiatives and Investment Delivering Intended Results STAMFORD, Conn.
Sign-up for Charter Announces Second Quarter 2014 Results investment picks
RAISES FULL YEAR NET SALES AND NET EARNINGS GUIDANCE AUBURN HILLS, Mich.
Sign-up for BorgWarner Reports Second Quarter 2014 U.S. GAAP Net Earnings Of $0.83 Per Diluted Share, Or $0.89 Per Diluted Share Excluding Non-Comparable Items investment picks
DEVENS, Mass., July 31, 2014 (GLOBE NEWSWIRE) -- AMSC (Nasdaq:AMSC) , a global solutions provider serving the wind and power grid industry, announced the availability of its newest wind turbine design.
Sign-up for AMSC Announces New 2 Megawatt Wind Turbine Designed for Low-Wind Speed investment picks
NEW YORK, July 31, 2014 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI) , a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the appointment of Michael Halstead as Senior Vice President and General Counsel.
Sign-up for Intra-Cellular Therapies Announces the Appointment of Michael Halstead as Senior Vice President and General Counsel investment picks
International Earnings Growth Driven by Continued Gains in Europe and Improving Operating Efficiency in Asia Pacific NEW YORK, July 31, 2014 (GLOBE NEWSWIRE) -- ITG (NYSE:ITG) , an independent execution and research broker, today reported results for the quarter ended June 30, 2014.
Sign-up for ITG Reports Second Quarter 2014 Results investment picks
2014/7/31
With KB Home’s unique homebuying experience, consumers have the freedom to design nearly every aspect of their home – both inside and out.
Sign-up for Experience the Great Outdoors in a New KB Home investment picks
LIONSGATE TO RELEASE FISCAL YEAR 2015 FIRST QUARTER EARNINGS AFTER MARKET CLOSE ON THURSDAY, AUGUST 7, 2014 AND TO HOLD ANALYST AND INVESTOR CONFERENCE CALL ON FRIDAY, AUGUST 8, 2014 Canada NewsWire SANTA MONICA, Calif.
Sign-up for LIONSGATE TO RELEASE FISCAL YEAR 2015 FIRST QUARTER EARNINGS AFTER MARKET CLOSE ON THURSDAY, AUGUST 7, 2014 AND TO HOLD ANALYST AND INVESTOR CONFERENCE CALL ON FRIDAY, AUGUST 8, 2014 investment picks
Noted for "Leading Desktop and Cloud Agile BI Tools" in Latest Research TYSONS CORNER, Va.
Sign-up for MicroStrategy Selected as an Agile BI Platform "Leader" in Report Published by Independent Research Firm investment picks
2014/7/31
Hecla Mining Company ( NYSE:HL ) today announced a second quarter net loss applicable to common shareholders of $14.5 million, or $0.04 per share, and a loss after adjustments applicable to common shareholders of $0.8 million, or $0.00 per share.
Sign-up for Hecla Reports Second Quarter 2014 Results investment picks
COLUMBIA, Md.
Sign-up for GP Strategies Reports Record Second Quarter 2014 Financial Results investment picks
NEW YORK, July 31, 2014 (GLOBE NEWSWIRE) -- Sequential Brands Group, Inc. ("Sequential" or the "Company") (Nasdaq:SQBG) will issue financial results for its second quarter ended June 30, 2014 before the market opens on Thursday, August 7, 2014.
Sign-up for Sequential Brands Group to Announce Second Quarter 2014 Financial Results on August 7, 2014 investment picks
ORLANDO, Fla.
Sign-up for Darden Announces Accelerated Stock Buyback investment picks
SALT LAKE CITY, July 31, 2014 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq:AMDA) , a biomaterial company focused on using its Silicon Nitride technology platform to develop, manufacture and sell a broad range of medical devices, announced today that it will release financial results for its second quarter 2014 on Thursday, August 7, 2014, at approximately 9:00 a.m. Eastern Time.
Sign-up for Amedica to Announce Financial Results for the Second Quarter of 2014 on Thursday, August 7, 2014 investment picks
2014/7/31
With access to a world-class Learning Library of games and apps, a kid-safe web experience out of the box, the latest and most powerful processor and a kid-tough design, LeapPad™3 is the best first tablet experience for children EMERYVILLE, Calif.
Sign-up for LeapFrog's Highest Performance Five-Inch Screen Children's Learning Tablet, LeapPad™3, Now Available investment picks
Span-America Medical Systems, Inc. (NASDAQ: SPAN) announced today that the Board of Directors increased the quarterly cash dividend by 7% to $0.15 per share.
Sign-up for Span-America Increases Quarterly Cash Dividend by 7% to $0.15 Per Share investment picks
The Ryland Group, Inc. (NYSE: RYL) today announced results for its quarter ended June 30, 2014.
Sign-up for Ryland Reports Results for the Second Quarter of 2014 investment picks
Perficient, Inc. (NASDAQ: PRFT) (“Perficient”), a leading information technology and management consulting firm serving Global 2000® and other large enterprise customers throughout North America, today reported its financial results for the quarter ended June 30, 2014.
Sign-up for Perficient Reports Second Quarter 2014 Results investment picks
SAN DIEGO , July 31, 2014 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) will announce financial results for the second quarter 2014, on Thursday, August 7, 2014 before markets open.
Sign-up for Orexigen Therapeutics to Host Second Quarter 2014 Financial Results Conference Call and Webcast investment picks
LAS VEGAS , July 31, 2014 /PRNewswire/ - Bakken Energy Corp formerly Orofino Gold Corp.
Sign-up for Bakken Energy Corp, announces the launch of new web-site and update on the name change, new symbol and dividend to shareholders investment picks
2014/7/31
VANCOUVER , July 31, 2014 /PRNewswire/ - Norsat International Inc. ("Norsat") (TSX: NII and OTC BB: NSATF), a leading provider of innovative communication solutions that enable the transmission of data, audio and video for remote and challenging applications, today announced that it will release its second quarter results for 2014 on Thursday, August 7, 2014 .
Sign-up for Norsat 2014 Second Quarter Earnings Release and Conference Call Notice investment picks
- Convertible Debt Retired for Common Stock - ADDISON, Texas , July 31, 2014 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR), today announced the retirement of the two convertible notes.
Sign-up for ULURU Inc. Eliminates Remaining Debt From The Balance Sheet investment picks
2014/7/31
WINNIPEG, MB and MIINNEAPOLIS, MN, July 31, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) will present at the InvestMNt 2014 Conference in Minneapolis at 8:15 AM Central Time on Wednesday, August 6, 2014 .
Sign-up for IMRIS CEO Jay D. Miller to present at InvestMNt 2014 Conference investment picks
2014/7/31
The Board of Directors of El Paso Electric (NYSE:EE) has declared a regular quarterly cash dividend on its common stock of $0.28 per share.
Sign-up for El Paso Electric Announces Quarterly Dividend investment picks
BlackRock Kelso Capital Corporation (NASDAQ:BKCC) (“BlackRock Kelso Capital” or the “Company”, “we”, “us” or “our”) announced today that its Board of Directors has declared a quarterly distribution of $0.21 per share payable on October 3, 2014 to stockholders of record as of September 19, 2014.
Sign-up for BlackRock Kelso Capital Corporation Declares Regular Quarterly Distribution of $0.21 per Share, Announces June 30, 2014 Quarterly Financial Results investment picks
Comparator will be pentazocine, a Schedule IV opioid receptor agonist with lower abuse potential than common opioids Top-line data expected in fourth quarter of 2014 SHELTON, Conn., July 31, 2014 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA) , a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain by selectively targeting peripheral kappa opioid receptors, today announced the initiation of a human abuse liability (HAL) trial of an intravenous formulation of its peripherally-selective kappa opioid agonist, CR845.
Sign-up for Cara Therapeutics Initiates Human Abuse Liability Trial of CR845 investment picks
2014/7/31
- Second-quarter highlights - North American onshore pro forma liquids volumes exceeded 201,000 barrels per day - Worldwide production averaged 636,000 barrels of oil equivalent (boe) per day; pro forma production averaged 550,000 boe per day - Generated earnings from continuing operations of $1.31 per diluted share/$505 million; adjusted earnings of $1.67 per share/$644 million - Operating activities provided net cash of $2.3 billion; $2.2 billion from continuing operations before changes in operating assets and liabilities - Repurchased 8.9 million shares of common stock - Company provides update on repositioning for North American onshore growth HOUSTON , July 31, 2014 /PRNewswire/ -- Apache Corporation (NYSE, Nasdaq: APA) today announced second-quarter 2014 earnings of $505 million or $1.31 per diluted common share and adjusted earnings, which exclude certain items that impact the comparability of results, of $644 million or $1.67
Sign-up for Apache reports 18 percent year-over-year pro forma North American onshore liquids growth for second-quarter 2014 investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: CombiMatrix's SNP-Based Miscarriage Analysis Test Granted Conditional Approval From New York State Department of Health to Apache reports 18 percent year-over-year pro forma North American onshore liquids growth for second-quarter 2014
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices